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Background: The DA rat strain is particularly susceptible to the induction of a number of chronic inflammatory
diseases, such as models for rheumatoid arthritis and multiple sclerosis. Here we sequenced the genomes of two
DA sub-strains and two disease resistant strains, E3 and PVG, previously used together with DA strains in genetically
segregating crosses.
Results: The data uncovers genomic variations, such as single nucleotide variations (SNVs) and copy number variations
that underlie phenotypic differences between the strains. Comparisons of regional differences between the two DA
sub-strains identified 8 genomic regions that discriminate between the strains that together cover 38 Mbp and harbor
302 genes. We analyzed 10 fine-mapped quantitative trait loci and our data implicate strong candidates for genetic
variations that mediate their effects. For example we could identify a single SNV candidate in a regulatory region of the
gene Il21r, which has been associated to differential expression in both rats and human MS patients. In the APLEC
complex we identified two SNVs in a highly conserved region, which could affect the regulation of all APLEC encoded
genes and explain the polygenic differential expression seen in the complex. Furthermore, the non-synonymous SNV
modifying aa153 of the Ncf1 protein was confirmed as the sole causative factor.
Conclusion: This complete map of genetic differences between the most commonly used rat strains in inflammation
research constitutes an important reference in understanding how genetic variations contribute to the traits of
importance for inflammatory diseases.
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The laboratory rat is a widely used model organism for
studying both basic mechanisms of physiology, and dis-
ease models of human diseases. Inbred rat strains and
genetically segregating crosses are important tools in func-
tionally proving disease mechanisms and represents a con-
trolled setting where molecular interactions between
different genetic factors as well as environmental factors
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reproduction in any medium, provided the orThere are many common characteristics between
chronic inflammatory diseases like Rheumatoid Arthritis
(RA) [2], and Multiple Sclerosis (MS) [3]: these diseases
are both consequences of dys-regulated immune re-
sponses that has initially been triggered by a combination
of genetic and environmental factors. Peripheral joints in
RA and myelin sheets in the central nervous system in
MS are the sites of persistent inflammation that leads to
tissue destruction. The most highly associated genetic re-
gion for the majority of these diseases is the Major Histo-
compatibility Complex (MHC) and especially HLA II
genes [4]. Despite recent progress in identifying loci that
associate with complex diseases in human [5], the identifi-
cation of the causative genetic polymorphisms, (both
within and outside MHC), and the understanding of their
pathophysiological roles, still represents a significantal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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eases lies not only in intricate interactions between genes
and environment, but also in elaborate genetic phenom-
ena such as gene-gene interactions, synergistic effects and
epigenetic mechanisms.
Animal models provide a means to control environmen-
tal factors and manipulate the genetic contribution. Al-
though the disease causing polymorphisms are not likely
to be identical with humans we expect the associated
pathophysiologic pathways to be conserved. Using animal
models could be a way to reveal their genetic complexity.
In addition, the environmental exposure can be controlled
and experimental manipulations are possible to perform.
One other benefit of using animal models for genetic re-
search is the possibility to selectively modify the genome
e.g. producing congenic, knock-out or transgenic strains
and linkage mapping.
DA rats are remarkably susceptible to a number of auto-
immune diseases; experimental arthritis induced with col-
lagen [6] or hydrocarbons such as mineral oil [7] or
pristane oil [8], experimental autoimmune encephalomy-
elitis [9], experimental allergic neuritis [10], experimental
allergic uveitis [11], and experimental autoimmune thy-
roiditis [12]. Also among other inbred rat strains, the DA
rat is the most prone to develop inflammation (Figure 1).
This disease susceptibility is mediated by both MHC and
non-MHC genes. It is the only strain susceptible to oil-
induced arthritis and other arthritis inducers provoke very
severe disease in DA compared to other susceptible strains.
It has been shown that DA rats from different colonies dif-
fer in disease susceptibility as well as contain distinct re-
gions of genetic differences [13], therefore we decided to
sequence 2 sub-strains of DA; DA/OlaHsd and DA/hanKini
( here abbreviated as DA/O and DA/K).
Genetic linkage studies using F2 animals from an
inter-cross between DA and different disease resistant
strains have identified about 50 quantitative trait lociFigure 1 The genomic influence on disease susceptibility. The influenc
by different genomes and MHC haplotypes. The illustration is an adaptatio(QTLs) associated with susceptibility to inflammatory
diseases. These QTLs together cover approximately 20
genomic regions in the DA rat that have been confirmed
in more than one F2 inter-cross (Figure 2). The first F2
cross that used DA as the inflammation susceptible
strain was a DA/K x E3 cross in Pristane induced arth-
ritis (PIA), that identified QTLs on chromosome 6, 4,
12, and 14 [8]. Three more arthritis mapping studies and
two in EAE utilizing DA/K x E3 F2 inter-crosses could
verify the first four QTLs and identified new QTLs on
chromosome 20 (MHC region), 10, 1, and 18 [15-19].
Dahlman et al. used a DA/K x ACI F2 cross in EAE to
identify QTLs on chr 4, 7, 10, 12, 13, 15, 18, and X [20].
The QTLs on chr 4, 10, 12, 15 were later confirmed in
DA/K x PVG.1AV1 advanced intercross line (AIL) [21-26].
In 1998 two arthritis QTLs were identified in LEW.1AV1x
PVG.1AV1 on chr 4 and 10 that later were replicated in a
DA/K x PVG.1AV1 F2 [27,28]. In 2003 a LEW.1AV1 x
PVG.1AV1 F2 cross identified two new QTLs on chromo-
some 1 and 17 [29] that were replicated in two DA/K x
PVG.1AV1 AIL populations [30-33]. The PVG.1AV1 is a
congenic strain sharing the MHC region with DA, but is
still resistant or develops extremely mild disease in re-
sponse to most inflammation inducers. The E3 strain is an
independent inbred rat strain that is highly resistant to
most inflammatory diseases but which tends to develop
obesitas and has a coagulation defect [34]. Aiming to iden-
tify genomic regions that differ between disease susceptible
and resistant strains, DA/O, DA/K, E3/han and PVG/
1AV1.Kini were selected for sequencing.
Since the main purpose of this sequencing effort has
been to create a tool to be used in all genetic studies of
the inflammatory rat we have also selected 10 quantitative
trait loci (QTLs) that are ~ 1 Mb in size, to dissect and re-
port all the variations in the interval. Main emphasis is
put on non-synonymous SNVs (nsSNVs), synonymous
SNVs (sSNVs), SNVs in UTRs, splice-site SNVs and SNVse of genomic variations on the development of inflammatory disease
n from [14].
Figure 2 Arthritis and EAE regulating QTLs in the DA genome. Chromosome maps illustrating the genomic intervals of inflammatory disease
regulating QTLs in the DA rat genome associated with mapping studies in DA/E3 or DA/PVG crosses and congenic strain.
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ent species (PhastCons9way). The new SNVs that are
identified will have to be analyzed in more detail and
assessed experimentally. However, they represent an
entry point for functional validation of candidate mo-
lecular genetic mechanisms underlying established
QTLs.
The identified QTLs that segregate between DA and E3/
PVG signify regions of regulatory importance in the devel-
opment of chronic inflammatory disease. Identifying the
underlying factors within these disease-regulating regions
would give important clues also for the diseases in human.
The complete genomic sequence of the DA strain and the
disease resistant strains E3 and PVG comprise invaluable
resources in the study of the polygenic nature of complex
diseases such as chronic inflammatory diseases.Results and discussion
Sequencing and variation calling
The four genomes DA/OlaHsd (DA/O), DA/hanKini
(DA/K), E3/han (E3) and PVG/1AV1.Kini (PVG) were se-
quenced in three separate runs using the SOLiD™ technol-
ogy. Aiming to also identify structural variations we made
three Mate-pair libraries with different insert sizes; 1 kb,
2 kb, and 4 kb as well as one paired end library. The reads
were then mapped to the BN (RGSC3.4) reference genome
with BWA [35]. This resulted in median coverage of 18-
22X (DA/O: 18X, DA/K 22X, E3 19X, PVG 19X) and en-
abled us to cover >99% of the BN reference sequence with
at least one read for all four genomes (Additional file 1).
SNVs and short indels were identified using a strategy
developed by Guryev et al [36]. To call a variant we re-



















Figure 3 Sequence similarities/differences between DA, E3
and PVG. Similarity is given as the percentage of SNVs shared
between combinations of strains out of all SNVs, after excluding
1.01 M positions where at least one strain is heterozygous or has a
coverage below 3. The number of SNVs kept for the analysis was
4166021. Total numbers of SNVs are in parenthesis.
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This predicted about 5.3 million SNVs and 0.4 million
short indels for all four genomes combined.
By comparing our SNVs with the genotypes from the
STAR consortium [37] we estimated the sensitivity to be
about 96.8-97.8%. In addition, we sequenced 100 regions
(300-500 bp in size) with capillary sequencing. Of the
178 SNVs identified by capillary sequencing 171 SNVs
were also identified by the SOLiD sequencing, whereas
two of the undetected SNVs were missed because less
than 75% of the reads carried the non-reference allele.
33 of the tested SNVs were in the coding sequence of a
gene and all these variants was identified in the SOLiD
SNVs. Four of the undetected SNVs are in the hyper-
polymorphic MHC region on chromosome 20. Further,
no false positives were identified in these sequences.
Variation analysis for the four genomes
SNVs
Each genome has about 3 million SNVs and 0.3-0.36
million indels compared to the BN reference. Approxi-
mately 70% of all SNVs are outside ref-seq annotated
gene regions. About 1% of the SNVs are located in cod-
ing regions, and 21% of the SNVs in coding regions are
non-synonymous (Table 1).
Pair-wise comparison identified that more than 98% of
the high-quality (≥ 8X coverage) SNVs in DA/O are
shared with the closely related DA/K. Analyzing the
SNP distribution of the strains showed that about 14%
of all SNVs identified are unique to DA/O and DA/K,
compared to BN, E3 and PVG (Figure 3). Further, 29%
of the identified SNVs are shared by all four genomes
and differ only from the BN reference sequence. A more
detailed distribution of the SNVs can be found in
Table 2.
Stop codons
Each strain has between 70–79 SNVs that results in a pre-
dicted premature stop codon (Additional file 2). This affects
a total of 131 genes, where about 60% are uncharacterized
genes or olfactory and vomeronasal receptors. Further, in
32 of these genes the stop codon was predicted in an alter-
natively transcribed gene, and not affecting all annotatedTable 1 SNVs and short indels (< 10 bp) compared to the
BN reference











DA/O 3.02 M 0.87 M 30440 6639 0.34 M 1206
DA/K 2.94 M 0.86 M 31130 6706 0.30 M 1243
E3 3.09 M 0.91 M 31426 6432 0.36 M 1294
PVG 2.99 M 0.86 M 31318 6432 0.30 M 1241
Cds = Coding sequence.transcripts from the gene. 33 of the stop introducing SNVs
were found in all 4 strains, whereas 56 are only present in
one strain, with 23 unique for DA, 14 for PVG and 19 for
E3. Furthermore, there is one stop gaining unique to the
DA/K strain in the Grb14 gene.
Structural variants
Next, we searched for structural variants between the
strains. We detected 45 duplications in the range of 0.4-
149 kbp, and 96 deletions between 1.8-134 kbp between
DA/O and E3 (Additional file 3). Deletions were predicted
to affect 96 genes in DA/O and 47 genes in E3. Fewer
genes (42) were affected by deletions in DA/K compared
to PVG and 36 genes in PVG compared to DA. The large
number of gene deletions in DA compared to E3 is to a
large extent due to deletions on chromosome 7 and 15,
most of which are also deleted in PVG.
Correlating SNVs in different genomic features with
differential expression and alternative splicing
Aiming to dissect the influence from SNVs occurring in
different coding or transcript regulatory sequences such as
splice-sites or UTRs, on differential expression and spli-
cing, we compared the occurrence of SNVs within a cer-
tain gene with the expression of that gene. Intragenic
SNVs were compared to a set of differentially expressed or
alternatively spliced genes from a study by Gillett et al.
[38]. In this study differential expression and alternative
splicing was analyzed in RNA from lymph node cells from
Table 2 A summary of identified high-quality SNVs (coverage > 8) between, DA/K and DA/O, DA/K and PVG and DA/O
and E3 and the distribution of SNVs across genomic features
DA/O≠DA/K DA/O≠E3 DA/K≠PVG DA/O+/K≠E3=PVG BN≠DA/O+/K+E3+PVG
Stop gained 1 48 37 22 10
Stop lost 0 3 2 1 2
Non-synonymous 108 3688 3374 1628 1437
Synonymous 224 7398 7546 3193 2770
Essential splice site 1 41 36 23 20
splice site 21 1013 973 451 401
5’prime UTR 21 644 692 270 231
3’ prime UTR 113 4761 4481 2029 1860
Intronic 13949 436591 347893 180040 171296
Uppstream 1322 49342 40423 19954 18148
Downstream 1215 41414 34053 16472 14919
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detected 13 genes with convincing evidence of differential
splicing between DA and PVG, of which three (Prex1,
Itpr2 and Nab1) have predicted splice site variants that are
unique to PVG. Further, 11 had coding SNVs. Naturally; it
needs to be further investigated if these are the variants
that lead to the altered splicing.
To assess the correlation between differential expres-
sion or splicing and SNVs on a larger scale, we looked
for SNVs in coding or UTR regions as well as in splice
sites in all genes with differential expression or splicing
between DA/K and PVG in the Gillett et al. study and
compared this with how often such SNVs occur in genes
that were not differentially expressed or spliced. There
was a significant enrichment of genes with SNVs in
UTRs and coding sequences among the genes that dis-
played differential expression compared to genes that
did not (Figure 4a). Due to the multiple probe design of
the Affymetrix arrays, the coding SNVs should not in-
fluence the actual hybridization to the array and thus
the difference should be reflecting the biology [39].
Similarly, there was an enrichment of genes with SNVs
in splice sites, UTRs and coding regions in alternatively
spliced genes compared to the genes where no alterna-
tive splicing was detected (Figure 4b). This suggests that
coding SNVs as well as SNVs in UTRs and in splice
sites are more frequent in genes that display differen-
tial expression or alternative splicing. However, there
are still many genes without the variants that are dif-
ferentially regulated. Hence, the absence of such vari-
ants cannot be used to exclude a gene as a candidate.
In addition, there are additional types of genomic vari-
ations, such as larger structural variants like partial
and whole gene duplications, which also need to be an-
alyzed, since they can have a major impact on gene ex-
pression and splicing [40].Pairwise comparison of disease susceptible and
resistant genomes
Comparing two DA sub-strains
There are more than 1 million of the identified SNVs be-
tween DA and E3 and between DA and PVG that could
contribute to the phenotypic difference. However, even be-
tween the very similar DA/O and DA/K there is a differ-
ence in sensitivity to arthritis induction [13]. Looking closer
at the polymorphic regions between DA/O and DA/K we
could show that the strains differ primarily in regions on
chromosomes 1, 2, 3, 7 and 13, which is in complete agree-
ment with the results by Rintisch et al. However, we were
able to better define the intervals, and two of the regions
could be divided in two distinct regions each and we also
found a new region on chromosome 5 that differs between
these sub-strains (Figure 5 and Table 3). In total, these eight
regions include approximately 38 Mbp and contain 302
genes of which 78 have nsSNVs or stop codon variants.
Congenic data showed no effect on disease sensitivity from
the region on chromosome 3 [13], hence the variants(s)
causing the different arthritis susceptibility are more likely
to be located on the other chromosomes, harboring in total
122 genes (Table 3).
To infer if the regions of differences are contaminations
from earlier crosses or hyper polymorphic regions, we com-
pared the SNVs in the regions with the STAR genotypes of
a number of other strains [37]. SNV comparisons show that
DA/K or DA/O displays an alternating pattern of identical
sequence to ACI in each of the identified intervals (Table 3).
The patchy pattern of the diverging regions between the
two DA strains is most likely the effect of the strains being
separated and inbred separately before the DA strain was
completely homozygous for all chromosomes.
The origin of the DA strain is often reported to be
unknown but it has been documented to be derived
from a stock from a Dr. T.T. Odell, Jr. at Oak Ridge
Figure 4 The association of SNVs in different gene regions and differential expression or splicing. Association of SNVs in different gene
regions and differential expression or splicing, as reported in Gillett et al. [38]. The fractions of genes that have SNVs in i) coding region, ii) UTR or iii) splice
sites were measured. a, Genes predicted to be differentially expressed between DA/K and PVG compared to genes with no differential expression in this
condition. Three different levels of fold change were used to categorize differentially expressed genes, resulting in 88 genes with fold change (FC) > 2, 214
genes with FC > 1.7, 520 genes with FC > 1.5 and 14140 genes with no differential expression. b, Alternatively spliced genes compared with genes with
no evidence of alternative splicing in this condition. Three significance levels were used to categorize significant alternative splicing in genes, resulting in
123 genes in the highest significance category p < 0.00001, 278 (p < 0.01), 613 (p < 0.1) and 13208 genes that were not considered alternatively spliced.
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scribes an agglutination test with an experimental set
up using animals from a cross between two inbred
lines that fits very well with what we now know about
the DA strain [41]. The first strain for the initial inter-
cross is an Irish coated strain that had been back-
crossed for 47 generations that express the D antigen
on their erythrocytes. This strain was most likely ACI
(see Table 3). The second inbred strain in the inter-
cross expressed the C antigen instead and had only
been backcrossed for nine generations. Some sugges-
tions of the C antigen strain are early generations of
the E3, BUF or LEW strains, which carry this allele.
The F1 progeny was then backcrossed to either the D
or the C strain. The D/D backcross population is most
likely the founder of the D-antigen expressing Agouti
coat color (i.e. DA) strain. Inbreeding was at inter-cross
generation 19 in about 1965. However a subset of the
DA colony was sent from Wistar to Oxford already in
1963, where it was further inbred. Thus, the two DA
sub-strains were separated at generation <19 before the
chromosomes had become homozygous which explainsthe dissimilar regions. It is also possible that more DA
sub-strains exist in laboratories throughout the world.
Functional comparison – genomic variance within
inflammation associated QTLs
Dissecting the genomic influence on inflammation re-
quests a lot of phenotypic data. Both linkage studies and
congenic mapping have identified ~20 genomic regions in
the DA rat associated to inflammatory disease (Figure 2).
The variation analyses of smaller QTLs, approximately 1
Mb in size, are described in more detail below and a sche-
matic overview of all inflammation QTLs identified in
comparisons of the three genomes irrespective of interval
size are described in Table 4.
Chromosome 1
Chromosome 1 harbors two regions of QTLs for both
EAE and PIA, [16,18,29,31,33,42], The fine-mapping of
the two QTLs down to a shorter genomic interval has
been done in EAE.
One QTL region Eea29/Pia8 is positioned close to the














Figure 5 DA/O and DA/K segregating SNV regions. SNVs between DA/O and DA/K plotted on the chromosomes. The dark bands are due to high
SNV density in 8 regions that distinguish DA/O and DA/K. Only positions supported by at least 8 reads in both strains were included in the picture.
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Mb using an AIL and they also validated the regulatory
effect using a 25 Mb congenic strain [31]. The refined
Eae29/Pia8 contains 18 genes. Beyeen et al. could show
differential gene expression in the genes IL22RA2 and
IFNGR1 and association to IL22RA2 could be shown in
a cohort of MS patients. Therefore these two genes are
strong candidates as regulators of inflammatory disease
and thus it is important to study all variants in the re-
gion for regulatory effects and if they coincide with con-
served regions. Comparing SNVs between the strains
DA and PVG in the shorter Eae29 region displayed very
little variation between DA and PVG. Surprisingly, only
16 SNVs were identified between 14.5-15.1 Mb. IL22ra2
had one SNV in the second intron and Ifngr1 had one
SNV in the first intron. To analyze if the SNV is in a
conserved segment and thus may be coinciding with a
regulatory element, the conservations score for the SNVsTable 3 DA/O and DA/K differentiating regions







1 225.91 229.22 ACI F344, BUF 3871 21
2 201.5 207.21 LE ACI 9084 74
218.22 219.01 ACI, E3 F344, BN 1482 6
3 34.7 52.32 ACI * (F344) 24496 80
73.21 78.08 ACI, F344, BUF * (WKY) 6287 100
Olfactory: 56
Other: 44
5 7.1 8.06 * * 1123 1
7 45.76 48.5 SHR, F344, WKY ACI 4352 13
13 33.3 35.6 ACI, SHR PVG, E3, BUF 5250 7
(* unclear).was assessed. The SNV is considered to be conserved if the
score is higher than 0.1, (http://hgdownload.soe.ucsc.edu/
goldenPath/rn4/phastCons9way/). Three of the SNVs in
Eae29 coincide with highly conserved regions (Figure 6a).
Further comparison of these SNVs to data from eight in-
bred rat strains [56] identified two SNVs in conserved re-
gions to be unique for the DA stain and the SNV in Il22ra2
is unique for DA and one of its ancestral genomes ACI
(Additional file 4).
The second QTL on chromosome 1 has been fine
mapped in both EAE and PIA from an interval between
176–218 Mb and was resolved into two distinct QTLs
Eae30 and Eae31. Eae31 is positioned to a region of less
than 1 Mb around 185 Mb and Eae30 to 1 Mb close to
128 Mb [33]. Eae31 was fine-mapped in both EAE and
PIA to five candidate genes and the region showed evi-
dence of association to human inflammatory disease to a




14 Dennd2d, Prok1, Slc16a4, Gstm7, Clcc1, Prmt6.
3 Arhgap29, Abca4, Dnttip2.
20 Slc39a11, Galnt5, Upp2, L:y75, Dpp4, Grb14 (Stop).




3 Ptprq, ENSRNOG00000030316 (Otogl).
2 ENSRNOG00000030901, Dpp10.
Table 4 A summary of all coding SNVs in EAE and arthritis regulating QTLs












Indels New candidate genes Evidence Strains Reference
1 PIA8 11 19 8 43 3 2 0 0 1 NS SNVs in Ect2l, and
ATG4B, indel in ALDH8A1
F2 DA.PVG, [42]
1 Eae29 15 17 3 18 2 1 0 0 1 conserved SNVs in IL22RA2,
short indel in ALDH8A1,
NS SNV in ATG4B
G10, congene DA/PVG [29,31]
1 Eae30 129 130 1 7 1 1 0 0 0 RGMA, NS SNV in Top1 G10, congene DA/PVG [29,33]
1 CIAA6/EAE6/7 156 247 91 1343 225 136 2 93 12 stopcodon in Ltbp3
and in Ms4a5
F2 BC DA/E3 [16]
1 Eae6 176 218 42 764 147 84 1 62 6 stopcodon in Ms4a5 F2 DA/E3 [18]
1 Eae31 185 185 1 6 3 2 0 1 0 IL21R 1 cons SNV, splice
site in IL4R, NS SNVs
in Gtf3c and LOC361646
G10, congene DA/PVG [15,29,33]
1 Eae7 240 247 7 64 25 16 0 12 1 indel in Myof, splice site
SNV in Znf518a
F2 DA/E3 [18]
4 PIA2/AIA2 32 42 10 28 7 6 0 3 2 indel in Dpp6, and frameshift
SNV in Tmem106b
F2 BC DA/BN, E3 [8,16]
4 Eae24 60 75 15 146 28 21 1 9 0 stop in an orf in a intron of
Dgki
G10, congene DA/PVG [21,43,44]
4 Eae25 75 83 8 88 22 19 0 6 1 indel in Znf282 (HUB1) G10, congene DA/PVG [21,43,44]
4 PIA5/CIA3 78 104 26 248 56 45 2 9 2 2 Stop in Igk genes F2 BC congene DA/BN,E3 [15,16]
4 Eae26 83 104 21 206 28 24 0 5 2 indel in Herc6, and RPS7 G10, congene DA/PVG [21,43,44]
4 Eae27 104 114 10 61 7 6 0 1 0 NS SNVs in both CD8a
and Cd8b
G10,congene DA/PVG [21,43,44]
4 Eae20 156 161 5 88 24 18 2 8 1 indel in Rad52, stop in
Clec4b2, stop in Q6QI20
G10, congene DA/PVG [24,44]
4 PIA7/OIA2/CIA13 159 160 1 23 8 6 2 2 0 stop in Clec4b2 F2 congene DA/E3,PVG [45,46]
4 Eae21 161 162 1 23 4 2 0 3 0 splice SNV in Pianp,
Zfp384, NS SNV Vwf
G10,congene DA/PVG [24,44]
4 Eae22 162 172 10 137 34 27 1 14 1 Essential splice site SNV
in Klrc2, stop Clec2
G10, BC DA/PVG [24,44]
5 CIAA5 138 172 34 554 113 92 1 27 4 Stop in orf, indel in Nmnat1,
Myom3, SZT2
F2 BC DA/E3 [15,16,18]
6 PIA3/eae9 117 144 31 249 70 55 1 16 6 stop in F1M0Z7_RAT F2 congene DA/E3 [15,16,18]
7 PIA13 62 78 16 116 15 12 0 2 1 indel in Ptdss1 F2 DA/E3 [15,16,18]
8 PIA14 79 87 8 53 11 8 0 3 0 splice site in Lrrc1, Ick, Eef1a1 F2 DA/E3 [15,16,18]
10 Vra4/Eae 0 11 11 94 13 11 0 2 0 no coding SNVs in Ciita congene DA/PVG [47,48]
10 Eae18a 55 67 12 303 67 47 1 20 2 stop in krt18-b, 2 NSC and





















Table 4 A summary of all coding SNVs in EAE and arthritis regulating QTLs (Continued)
10 Eae18b 67 72 5 68 22 12 0 10 2 CCL11 conserved SNVs G7,G10,cong. DA/PVG [20,25,30,49]
10 CIA5A OIA3
PIA10 EAN5
95 110 15 214 36 29 0 8 3 Cd300 hyper polymorphic





11 Pia27, RF 84 86 2 53 6 4 0 2 1 Essential splice site in Lac2 F2 congene DA/E3 [51]
12 Eae5 20 24 4 70 16 11 0 5 0 NCF1, CLN4, splice
site SNV i Gtfi1
G7, congene DA/PVG [28,49]
12 PIA4/NCF1 * 1 NCF1 NS SNV aa153 congene DA/E3 [16,52]
14 PIA6/EAE10/
CIAA7
32 103 71 408 39 25 0 12 3 NS SNV Tlr10, Igfbp3, indel
Aebp1, Apex2
F2 DA/E3 [53,54]
15 Eae19 83 97 14 33 7 7 0 1 0 Lmo7, Tbc1d4, Mycbp2,
Uchl3, Slitrk6
G7,congene DA/PVG [20,26]
17 Eae23a 36 57 21 180 13 12 0 1 0 NS SNVs in Ripk1, Serpinb1a,
Gpx6, splice-SNV in Agtr1a
G10, cong. DA/PVG [29,32,55]
17 Eae23b 57 66 9 49 11 8 1 3 1 stop in Prelid1 G10, cong. DA/PVG [29,32,55]
20 Pia1 3 5 2 114 50 40 1 16 0 NS SNVs in Ncr3, Lst1, RT1-Ba,






















































Rat Nov. 2004 (Baylor 3.4/rn4)   chr10:70,274,337-70,288,299 (13,963 bp)
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Figure 6 Snapshots from the UCSC genomic web-browser describing the genomic locations of the identified SNVs within 4 QTLs or
specific genes in QTLs (a-d). The SNVs are depicted as red or blue bars in the top of the illustration. The number next to the bar corresponds
to the SNPs individual number in the series of all SNPs in the QTL. Blue bars indicate SNVs with conservation score higher than 0.1, in red are
SNVs less that 0.1. The mid segment of the snapshot contains the genes in the interval and below is the degree of inter-species conservation
illustrated as blue and green bars.
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http://www.biomedcentral.com/1471-2164/15/391identified in the IL21R gene in the rat, but the IL4RA
gene had a splice site SNV. Four SNVs are unique to
DA (Additional file 4). In addition, two other genes in
the region, Gtf3c and LOC361646, displayed numerous
nsSNVs. Further, looking at SNVs in conserved regions
identified 5 potentially regulating SNVs (Figure 6b). The
IL4RA gene also contains two sSNVs, whereas the IL21R
gene contains one potentially regulating SNV in an intron
(conservation score 0.45).In the Nohra et al. study [33], an additional 1.1 Mb EAE
specific QTL Eae30 close to the RGMA gene was identi-
fied in a G10 AIL. Interestingly, there was suggestive asso-
ciation to the human RGMA gene also in an MS cohort.
There are 48 polymorphisms between DA and PVG in
RGMA. Ten of the variants are of potential interests; three
SNVs in conserved regions and one synonymous SNV in
the last exon. Four SNVs in the region are unique for DA/
ACI (Additional file 4).
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Rat chromosome 4 is one of the most QTL dense re-
gions in the DA genome. Three regions have been linked
to EAE and arthritis. The QTL Pia5/Eae24-27 have also
been linked to experimental diabetes [57] and uveitis
[58]. There is also evidence that the chromosome has re-
gions of epistatic genetic interactions [43].
The original Pia5/Eae24-27 locus is more than 20 Mb
and covers 250 to 500 genes depending on the study and
disease model [16,43]. Among the genes in this region
are TCRBV, Ig Kappa genes and IL23R, with potential
profound importance in immune regulation. In 2010
Marta et al. used a combination of congenic lines as well
as an advanced intercross line to dissect disease regula-
tion in this region. They showed that the effect on dis-
ease regulation was larger than the effect from any of
the smaller congenic strains, however one small (1.25
Mb) congenic strain (R23) mediates a major part of the
regulatory effect from this region. No coding variations
could be identified between DA and PVG in this region,
which indicates that the disease regulating variation is
regulatory. Indeed, this region is very conserved between
species and of the 1810 SNVs in the interval 188 coin-
cided with conserved genomic intervals. Not surpris-
ingly, many of the genes in the region have important
function in embryonic development.
Next, the arthritis QTL Oia2/Pia7 at 159.46-160.0
Mb is known to be a strong regulator of adjuvant-
induced arthritis such as OIA or PIA [42,45,46]. Fur-
ther, this arthritis QTL coincides with the EAE QTLs
EAae20-21 [24]. The region harbors the APLEC com-
plex, which encodes a set of C-type lectin receptor
genes expressed on antigen presenting cells. Most
of the APLEC genes have been shown to be differen-
tially expressed after stimulation with a number of
immune-triggering stimulants [45,59]. There are a
number of coding polymorphisms in the APLEC com-
plex encoded genes. One generates a premature stop-
codon in Clec4b2 in the DA genome and is certainly a
plausible candidate to mediate the disease phenotype.
However, four other APLEC encoded genes have non-
synonymous SNVs between DA and E3/PVG. Further-
more, a total of 832 SNVs could be identified in the
550 kb consensus region and 33 polymorphisms lie
within conserved regions in or close to genes. Neither
of the SNVs in the APLEC complex are unique to DA
but are shared between at least five other inbred ge-
nomes (Additional file 4) [56]. One region at 159.955
kb has the maximum conservation score = 1, accord-
ing to the phastCons9way, and could be a regional en-
hancer for the APLEC genes in the region. This region
harbors two SNVs. This region needs to be analyzed
further to conclusively determine weather this is an
enhancer or not.Chromosome 10
Chromosome 10 harbors at least four susceptibility genes
for experimental inflammatory disease. Proximal to the
centromere is the Vra1/Ciita gene locus [47,48], which is
part of a haplotype identified to regulate levels of MHC
class II expression, and which was also reported to be as-
sociated with chronic inflammatory disease [48]. The vari-
ant underlying the effect has however not been identified.
Ciita contains no nsSNVs between DA and PVG. How-
ever, there are three synonymous coding SNVs that may
influence the expression levels of which two are unique
for E3/PVG (Additional file 4). In addition, there are a
number of polymorphisms in conserved regions with po-
tentially regulatory effect on the gene. The 19 kb upstream
promoter of Ciita harbors two very conserved regions
with 10 SNVs of which one is unique to E3/PVG.
The mid-part of chromosome 10 has been associated
with both EAE and arthritis Eae18/Cia5/Oia3 [25,50,60].
Eae18 QTL was fine-mapped using two AILs, G7 and G10,
which divided the QTL in two QTLs, Eae18a and Eae18b
[25]. EAE18a was fine-mapped to 1.1 Mb harboring 13
genes at 58.2-59.3 Mb [22]. Two nsSNVs in Fam64a and
ENSRNOG00000037371, as well as two SNVs in splice-
sites of RGD1304728 and Smtln2 were identified in the
Eae18a locus, in addition to several potentially regulating
SNVs.
Eae18b was fine-mapped to a 0.88 Mb region between
70.2-71.0 Mb in a G10 AIL [49]. Two genes in this region
Ccl2 and Ccl11 showed differential expression. Interest-
ingly, differential expression of Ccl2 has also been ob-
served between MS patients and controls. However in a
functional characterization study of the Eae18b congenic
strain, Ccl11 was conclusively identified to be regulating
many different disease pathways in this strain [30]. Ccl11
has six SNVs in the 3′UTR of which four are in conserved
sequences; the gene also has one conserved intronic SNV
and one synonymous SNV (Figure 6c).
In experimental arthritis a QTL has been identified in
both DA/PVG and DA/F344 crosses on chromosome 10
[14,50,60]. This arthritis specific QTL was fine-mapped
in pristine-induced arthritis using an AIL G10 [14]. Also
for this QTL the locus was separated in to two regions.
Interestingly the second 1.5 Mb region coincided with a
region with Cd300 like genes, which contain distinct re-
gions of very high variation between DA and the other
strains (Figure 6d). The aggregation of SNVs in the
vicinity of Cd300 genes may be an indication of struc-
tural variations in the region and needs to be further
studied, however these genes could have a significant
influence on the regulation mediated by this region.
Interestingly this locus was not mapped in any of the
DAxE3 F2 crosses, which suggests that the regulating
polymorphism(s) could be unique to the PVG strain. In
the other region Pia30, 114 SNVs were identified that
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intronic or intergenic SNVs in or near the Rpl38 and
Ttyh2 genes.
Chromosome 12
The first arthritis regulating QTL to be cloned and posi-
tioned to one polymorphism is the Pia4, which was identi-
fied to be regulating chronic inflammation by a non-
synonymous SNV in the Ncf1 gene, altering the amino acid
at position 153 [52]. It was originally mapped using both
PIA (Pia4) [8] and EAE models (Eae5/Eae11) [18,23]. The
gene was identified using a congenic strain with E3 alleles
between 23.476-23.730 Mb and harbors three genes. Here,
a total of 377 SNVs were detected between DA and PVG/
E3 in the Pia4 region. Five of them are coding variants, of
which one is non-synonymous and one is annotated to be
in a splice site of Gtf2i. Moreover, 7 SNVs are located in
UTRs of which 5 are in the 3′UTR of the Ncf1 gene, but
they have low conservation scores. Five SNVs are in poten-
tially conserved regions, but only one of them, the nsSNV,
is in Ncf1. Hence, the genome sequences support the previ-
ous findings that the inflammation regulatory effect from
this congenic is mediated by the Ncf1 nsSNV [61].Conclusions
DA rats are particularly susceptible to the induction of a
number of chronic inflammatory diseases. There is a
modest difference in arthritis susceptibility between the
two strains where DA/O is slightly more susceptible.
Here we identified eight polymorphic regions between
two substrains of DA; DA/K and DA/O together cover-
ing 38 Mb of genomic sequence. Of the variable regions,
23 Mb are located on chromosome 3 and by using a
DA/O.chr3DA/K congenic strain these regions were ex-
cluded as important in arthritis regulation [13], and thus
the regulatory effect should come from the remaining
15 Mb variable regions between DA/O and DA/K.
According to the rat genome database more that 50 in-
flammatory disease related QTLs have been identified in
the DA rat. Here we have used the next-generation sequen-
cing of the DA genome and inflammatory disease resistant
E3 and PVG to investigate 10 fine-mapped QTLs and
closely catalogue the complete set of variations in these re-
gions. This study has identified a number of interesting
non-synonymous or regulatory variants within these QTLs.
For the already positionally cloned gene, Ncf1, in the
Pia4 QTL on chromosome 12, no additional regulatory
SNVs were identified in the proximal region of Ncf1 that
are likely to contribute to the regulation of inflamma-
tion in the region. Hence, this further enhances the im-
portance of the previously detected nsSNV (coding for
aa153 of the protein) in the regulation of experimental
inflammatory disease.Two of the inflammatory-disease regulating regions
analyzed here; the Vra1/Ciita and Eae25/R23 loci are
completely devoid of coding SNVs, but do contain sev-
eral SNVs in conserved regions, indicating regions of
regulatory function.
Four of the QTLs (Eae29, Eae30, Eae31 and Eae18b)
have strong candidate genes that have been identified to
be differentially expressed between DA and PVG as well
as associated to chronic inflammatory disease in human
cohorts. These gene-regions were analyzed for regulatory
polymorphisms. Eae29 has three very good regulatory
SNV candidates that should be assessed for disease regula-
tion in the vicinity of IL22ra2. The expression of IL22ra2
has been demonstrated to differ between the strains impli-
cating difference in regulatory regions [31]. IL22RA2 is
now one of the well-established MS risk genes [62]. Eae30
has one non-synonymous SNV in a topoisomerase like
gene, however this gene may not be the disease-regulating
gene in the interval. RGMA, which is the top candidate
gene in the region, contains 4 conserved regions with pos-
sible regulatory SNVs. The top candidate gene for the
Eae31 locus is Il21r. This gene has only one identified
SNV with potential regulatory function in the first intron
of the gene. Eae31 also contains a splice site SNV in the
Il4ra gene plus two potential regulating SNVs that also
should be tested for EAE regulation. The QTL Eae18b
harbors the Ccl11 gene that have shown strong immune-
regulatory effects in inflammatory disease [30]. Ccl11 con-
tains five highly conserved SNVs and particularly four
SNVs in the 3′UTR are strong candidates to be regulators
of differential expression.
The APLEC locus on chromosome 4 harbors five nsSNVs
in four genes. This region contains very few conserved re-
gions, however a new impending regulatory region 50 kb
upstream of the last gene (Mincle) in the complex was
identified that contains two SNVs in the middle of the con-
served region. This region has to be analyzed further to
fully comprehend if and how it could regulate all genes in
the region.
A hyper-variable region in Pia30 on chromosome 10
was also identified. This region contains four SNV dense
regions of about 10 kb in size each. These variable re-
gions occur in the extended 3′UTR of Cd300 genes,
Cd300b and Cd300f in particular. This enrichment of
SNVs in a short interval may perhaps be explained by
sequence duplications/divergence.
By combining information for the most interesting SNVs
in the herein analyzed QTLs with SNV information from
an eight genome sequencing study of inbred rats [56], we
identified a number of SNVs unique for inflammation sus-
ceptible DA and the inflammatory disease resistant PVG
and E3 strain. Three QTLs had DA or DA/ACI unique
SNVs and one had E3/PVG unique SNVs. Out of the eight
QTLs that were used in this comparison only four had
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few cloned chronic inflammatory disease regulating SNV,
in the Ncf1 gene, also is present in the inbred strains BUF,
F344 and WKY. The strain BUF is susceptible to both arth-
ritis and EAE whereas both F344 and WKY are resistant to
experimental arthritis. The disease regulation mediated by
this SNV is however very strong and has been confirmed
to be disease regulating also in mice. This demonstrates
that additional protective genes in the genome may mask
even very strong disease enhancing SNV effects.
In a genotype to phenotype perspective, the combined
effect from the QTLs has profound functional implica-
tions. In short, both the adaptive and innate immunity is
affected; The Ncf1 gene is involved in the first defense
against infections and triggering the immune system.
Both the CD300 and the APLEC encoded genes are im-
portant pattern recognition receptors involved in antigen
uptake and Ciita is important in regulating antigen pres-
entation. The chemokine Ccl11 and the cytokine receptors
Il21r and Il22ra2 are important in modulating the immune
responses leading to inflammation. Il21r and Il22ra2 are
particularly important regulators of activated T cells. In
conclusion the 10 QTLs represent regions of important
disease regulation and the combined effect explains a sub-
stantial part of the pro-inflammatory phenotype that is
characteristic of the DA strain.
The full genomic sequence of DA/O, DA/K, E3 and
PVG constitutes an invaluable resource in the understand-
ing of how polymorphisms in the DA genome contribute
to disease susceptibility and this genetic blueprint of an in-
flammation permissive rat strain will also be important in
the understanding of the human etiologies for chronic in-
flammatory disease.Methods
Next-generation sequencing
Liver samples from 1 female rat per strain was used for all
runs. The sequences were generated in 3 separate runs.
The first run (august 2009) was achieved using a SOLiD™3
sequencer with 1 full slide per sample. The Mate-pair li-
brary protocol was used to generate 2 × 50 bp reads, with
2–3 kb insert size. A Hydro-shear was used for fragmenta-
tion. The libraries were produced after 11 cycles of amplifi-
cation. The second run (September 2010) was performed
using a SOLiD™4 and generating 2 Mate-pair libraries per
genome, one with 1 kb insert size and one with 4–4.5 kb
insert sizes. ¼ of a slide was used for each library and the li-
braries were amplified 10–15 times. The DNA samples
were fragmented using a Covaris S2. The last sequencing
run using the Fragment library protocol was done on a
SOLiD™5500 (June 2011). 3 lanes of 75 X 35 bp reads were
run per sample. Fragmentation to 150–200 bp was achieved
by a Covaris S2 with 6 cycles of amplification. All librariesin the study were quality controlled on an Agilent Bioanaly-
ser High sensitivity Chip + qPCR.
Mapping
The reads were aligned to the BN reference assembly
(Rnor3.4) with the BWA (v0.5.9) aligner (−c –l 25 –k 2 –n
10). Mapped reads from all libraries were merged before
SNV calling. The yield of sequence mapping to the genome
was 48.9 Gb for DA/O, 50.8 Gb for DA/K, 59.9 Gb for E3/
han and 51.8 Gb for PVG/1AV1.Kini (Additional file 1).
SNV/Indel calling
SNV and short indel calling was done with a strategy de-
veloped by Guryev [36] based on Samtools pileup [63].
Duplicate reads (starting at the same position) were dis-
carded. Next, each SNV should be supported by at least
three calls with a quality > 10. In addition, we used only
SNVs where at least 75% of the reads support the non-
reference allele (40% for indels). Finally, SNVs that dif-
fered between the reference and the resequencing of the
original reference rat (Eve), were removed since these
are likely to be errors in the reference. This resulted in a
total of 5.2 M SNVs and 0.66 M short indels (< 10 bp),
of which about 57% were deletions and 43% insertions.
A “high-quality SNV set” was compiled of SNVs with at
least 8 X coverage. About 97% of the genome was covered
by at least 3 calls and 85% by 8 or more.
The functional annotations of all SNVs were predicted
with the Ensembl Variant Effect Predictor [64].
These strains have been inbred for many generations and
should be homozygous at nearly all positions. Therefore we
excluded approximately 0.9 M positions per strain where
25-75% of the reads supported the variant allele. Almost
10% of these variants are detected in regions with high
coverage (>30X), compared to <1% for homozygous SNVs,
and may be due to duplications, as suggested previously
[40]. Further, we found that 7% of the heterozygous SNVs
in DA/O (coverage 9-25X) were called as homozygous
SNVs in DA/K, whereas 1% were called as reference.
Hence, some heterozygous SNV calls are likely true SNVs
which are missed due to low coverage and errors in se-
quencing/alignment.
To estimate the SNV calling sensitivity we compared
our SNVs with a set of 20284 SNVs typed by the STAR
consortium [37]. In this set, 11241, 11037 and 11253
SNVs differed between BN and DA, E3 and PVG, re-
spectively, of which, we detected between 96.8-97.8% in
all strains. We also sequenced a number of SNV dense
regions with conventional Sanger sequencing. Out of the
178 SNVs detected by Sanger sequencing, 171 could be
detected by the SOLiD sequencing, whereas two were
predicted by less than 75% of the reads and thus were
false negatives. No false positives were found with
SOLiD in these regions.
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using STAR genotypes and the Sanger sequenced re-
gions did not contain any indels, however it is likely that
the sensitivity is substantially lower. Indeed, we found
that only 66% of the indels called in DA/O were con-
firmed in DA/K.
CNV calling
Copy number variation (CNVs) due either to deletions
or duplications of regions. were predicted with DWAC-
seq version 0.56 to identify CNVs. This program counts
the reads in a window of dynamic size and compares
these counts for two strains. We counted only uniquely
mapped reads and used a ratio below 0.3 for deletions
and above 1.6 for duplications. To better distinguish
CNVs from repetitive regions, we only allowed regions
with one strain having a mean coverage around the
mean genome coverage (±0.5* mean coverage). Further,
regions were only predicted as deletions if the number
of bases lacking coverage differed by at least 10% be-
tween the strains.
Ethics statement
All experiments in this study were approved and performed
in accordance with the guidelines from the Swedish Na-
tional Board for Laboratory Animals and the European
Community Council Directive (86/609/EEC) under the eth-
ical permit N332/06entitled ‘Genetic regulation, pathogen-
esis and therapy of EAE, an animal model for multiple
sclerosis’, which was approved by the North Stockholm
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tiska nämnd). Rats were tested according to a health-
monitoring program at the National Veterinary Institute
(Statens Veterinärmedicinska Anstalt, SVA) in Uppsala,
Sweden.
QTL analysis
QTLs smaller than 1 Mb in interval were selected for
finer SNV analysis. SNVs were visualized using the add-
custom track function in the UCSC web browser. The
conservation scores (phastCons9way) where downloaded
from the UCSC. http://hgdownload.soe.ucsc.edu/goldenPath/
rn4/phastCons9way/. In order to retrieve information on
unique SNVs in the smallest QTLs, conserved SNVs or
nsSNVs in the QTLs were compared to eight inbred rat
strains [56] in a 13 genome comparison.Accession numbers
The sequence data for all four genomes will be available
from the European Bioinformatics Institute short read
archive under the accession number: ERP0004908. All
variants identified in this study will be available from the
rat genome database (http://rgd.mcw.edu).Additional files
Additional file 1: Yield and coverage for sequence libraries. Table
describing the different libraries that were created, and the yield and
genome coverage from sequencing.
Additional file 2: Stop-gained or stop-lost nsSNVs. Table with nsSNVs
that generates stop-gained or stop-lost.
Additional file 3: Insertions and deletions. Table describing insertions
and deletions identified in the sequencing study.
Additional file 4: A 16 rat strain SNV analysis within eight
inflammation associated QTLs. Table including SNV information for 9
rat strains [56] within eight of the smallest QTLs discussed in the Results
section. The SNV that are included in the table are all identified nsSNVs,
sSNVs splice-site variants and conserved SNVs.
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